Sagimet plans to start acne drug trial enrollment in Q4.
Finance Review Daily is tracking this development following a report from Investing Stock. Additional confirmed specifics had not been verified at the time of publication.
Sagimet plans to start acne drug trial enrollment in Q4
Finance Review Daily is tracking this developing story; additional confirmed specifics had not been verified at the time of publication.
SL
Sophie Laurent · FX & Rates Desk · 25 Aug 2026 · 11:21 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
SL
Written by
Sophie Laurent
FX & Rates Desk
Sophie covers currency markets and central bank policy across Europe, with a focus on how rate decisions ripple through FX pairs. She has been tracking the ECB's policy path since the start of the current easing cycle.
More from Sophie Laurent →
